These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 590994)

  • 21. Inhibition of lymphocyte triggering by cytochalasin B.
    Yoshinaga M; Waksman BH; Malawista SE
    Transplant Proc; 1972 Sep; 4(3):325-7. PubMed ID: 5080603
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of macrophages in the production of lymphokines by T and B lymphocytes.
    Wahl SM; Wilton JM; Rosenstreich DL; Oppenheim JJ
    J Immunol; 1975 Apr; 114(4):1296-301. PubMed ID: 1090672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids.
    Wahl SM; Altman LC; Rosenstreich DL
    J Immunol; 1975 Aug; 115(2):476-81. PubMed ID: 1097517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxyribonucleic acid synthetic response of mouse lymphoid cells in microculture with T-lymphocyte-dependent mitogens.
    Williams RM; Benacerraf B
    Lab Invest; 1975 Mar; 32(3):382-7. PubMed ID: 1079068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses.
    Farrar WL; Mizel SB; Farrar JJ
    J Immunol; 1980 Mar; 124(3):1371-7. PubMed ID: 6153680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
    Thomson AW; Moon DK; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of mouse thymus cells response to periodate treatment by a soluble factor.
    Novogrodsky A; Gery I
    J Immunol; 1972 Dec; 109(6):1278-81. PubMed ID: 4538964
    [No Abstract]   [Full Text] [Related]  

  • 28. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lectin-induced phosphatidylinositol metabolism in lymphocytes is potentiated by macrophages.
    Grier CE; Mastro AM
    J Immunol; 1988 Oct; 141(8):2585-92. PubMed ID: 2844903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of action of "lymphocyte activating factor" (LAF)--II. LAF effect is resistant to elevation of cellular cyclic AMP.
    Kierszenbaum F; Waksman BH
    Immunochemistry; 1978 Nov; 15(10-11):807-11. PubMed ID: 218885
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulatory substances produced by lymphocytes. II. Lymphotoxin in the rat.
    Namba Y; Waksman BH
    J Immunol; 1975 Oct; 115(4):1018-22. PubMed ID: 1080770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adriamycin effects of PHA-stimulated lymphocytes].
    Lutz D; Haist B; Stacher A
    Int J Clin Pharmacol Biopharm; 1975 Apr; 11(3):226-31. PubMed ID: 1150368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of mitogenic factor by mouse lymph node cells stimulated with PHA in vitro. Inhibition of this phenomenon by the addition of thymocytes.
    Jacobsson H; Blomgren H
    J Immunol; 1975 May; 114(5):1623-30. PubMed ID: 1079041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte populations of AKR-J mice. I. Effect of aging on migration patterns, response to PHA and expression of theta antigen.
    Zatz MM; Golstein AL; White A
    J Immunol; 1973 Nov; 111(5):1514-8. PubMed ID: 4744926
    [No Abstract]   [Full Text] [Related]  

  • 35. T cell products activating stem cells: further studies on the origin and action of the factor(s).
    Cerny J; Waner EB; Rubin AS
    J Immunol; 1975 Aug; 115(2):513-8. PubMed ID: 1080170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
    Shitara K; Ichimura O; Mitsuno T; Osawa T
    J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte population of AKR-J mice. II. Effect of leukemogenesis on migration patterns, response to PHA, and expression of theta antigen.
    Zatz MM; White A; Goldstein AL
    J Immunol; 1973 Nov; 111(5):1519-25. PubMed ID: 4744927
    [No Abstract]   [Full Text] [Related]  

  • 38. The in vitro role of thymus-dependent cells in DNA synthesis and LT secretion by PHA-stimulated mouse lymphoid cells.
    Shacks SJ; Chiller J; Granger GA
    Transplant Proc; 1972 Sep; 4(3):303-5. PubMed ID: 5080602
    [No Abstract]   [Full Text] [Related]  

  • 39. The tumour promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) induces the production of lymphocyte-activating factors (LAP) in human lymphocyte cultures.
    Abb J; Deinhardt F
    Arch Geschwulstforsch; 1980; 50(4):327-31. PubMed ID: 6970023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 5-mercapto-2'-deoxyuridine on the incorporation of nucleosides into RNA and DNA in a primary lymphocyte culture system.
    Bogyo D; Bardos TJ; Chmielewicz ZF
    Cancer Res; 1976 Sep; 36(9 pt.1):3284-93. PubMed ID: 975090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.